nodes	percent_of_prediction	percent_of_DWPC	metapath
Almotriptan—CYP2C8—Medroxyprogesterone Acetate—uterine cancer	0.138	0.197	CbGbCtD
Almotriptan—CYP2C8—Progesterone—uterine cancer	0.0917	0.13	CbGbCtD
Almotriptan—CYP2C19—Progesterone—uterine cancer	0.0769	0.109	CbGbCtD
Almotriptan—CYP1A2—Progesterone—uterine cancer	0.071	0.101	CbGbCtD
Almotriptan—CYP2D6—Progesterone—uterine cancer	0.0585	0.0831	CbGbCtD
Almotriptan—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.0561	0.0798	CbGbCtD
Almotriptan—CYP2E1—Etoposide—uterine cancer	0.0549	0.0781	CbGbCtD
Almotriptan—CYP2C8—Etoposide—uterine cancer	0.041	0.0583	CbGbCtD
Almotriptan—CYP3A4—Progesterone—uterine cancer	0.0372	0.0529	CbGbCtD
Almotriptan—CYP1A2—Etoposide—uterine cancer	0.0318	0.0452	CbGbCtD
Almotriptan—CYP2D6—Doxorubicin—uterine cancer	0.0178	0.0254	CbGbCtD
Almotriptan—CYP3A4—Etoposide—uterine cancer	0.0166	0.0237	CbGbCtD
Almotriptan—CYP3A4—Doxorubicin—uterine cancer	0.0113	0.0161	CbGbCtD
Almotriptan—HTR1B—artery—uterine cancer	0.00306	0.116	CbGeAlD
Almotriptan—HTR1D—artery—uterine cancer	0.00296	0.112	CbGeAlD
Almotriptan—FMO3—mammalian vulva—uterine cancer	0.00171	0.065	CbGeAlD
Almotriptan—Melatonin—CYP19A1—uterine cancer	0.0014	0.521	CrCbGaD
Almotriptan—FMO3—vagina—uterine cancer	0.00133	0.0504	CbGeAlD
Almotriptan—Melatonin—ESR1—uterine cancer	0.00129	0.479	CrCbGaD
Almotriptan—MAOA—myometrium—uterine cancer	0.00109	0.0413	CbGeAlD
Almotriptan—HTR1B—female reproductive system—uterine cancer	0.000861	0.0327	CbGeAlD
Almotriptan—FMO3—lymph node—uterine cancer	0.000859	0.0326	CbGeAlD
Almotriptan—MAOA—uterine cervix—uterine cancer	0.000848	0.0321	CbGeAlD
Almotriptan—HTR1D—female reproductive system—uterine cancer	0.000834	0.0316	CbGeAlD
Almotriptan—MAOA—decidua—uterine cancer	0.000807	0.0306	CbGeAlD
Almotriptan—MAOA—renal system—uterine cancer	0.000793	0.0301	CbGeAlD
Almotriptan—MAOA—endometrium—uterine cancer	0.000767	0.0291	CbGeAlD
Almotriptan—MAOA—mammalian vulva—uterine cancer	0.000741	0.0281	CbGeAlD
Almotriptan—CYP2C8—renal system—uterine cancer	0.000707	0.0268	CbGeAlD
Almotriptan—MAOA—uterus—uterine cancer	0.000706	0.0268	CbGeAlD
Almotriptan—CYP2C8—endometrium—uterine cancer	0.000683	0.0259	CbGeAlD
Almotriptan—CYP1A2—renal system—uterine cancer	0.000662	0.0251	CbGeAlD
Almotriptan—MAOA—female reproductive system—uterine cancer	0.000635	0.0241	CbGeAlD
Almotriptan—CYP2E1—renal system—uterine cancer	0.000595	0.0226	CbGeAlD
Almotriptan—CYP2C19—vagina—uterine cancer	0.000587	0.0223	CbGeAlD
Almotriptan—MAOA—female gonad—uterine cancer	0.000578	0.0219	CbGeAlD
Almotriptan—MAOA—vagina—uterine cancer	0.000574	0.0218	CbGeAlD
Almotriptan—CYP2C8—female reproductive system—uterine cancer	0.000566	0.0215	CbGeAlD
Almotriptan—Malaise—Dactinomycin—uterine cancer	0.000561	0.00225	CcSEcCtD
Almotriptan—Salivary hypersecretion—Epirubicin—uterine cancer	0.00056	0.00225	CcSEcCtD
Almotriptan—Colitis—Epirubicin—uterine cancer	0.000554	0.00223	CcSEcCtD
Almotriptan—Coordination abnormal—Doxorubicin—uterine cancer	0.000544	0.00219	CcSEcCtD
Almotriptan—Neuropathy—Epirubicin—uterine cancer	0.000542	0.00218	CcSEcCtD
Almotriptan—Neck pain—Doxorubicin—uterine cancer	0.00054	0.00217	CcSEcCtD
Almotriptan—Feeling abnormal—Medroxyprogesterone Acetate—uterine cancer	0.000536	0.00215	CcSEcCtD
Almotriptan—Ventricular tachycardia—Doxorubicin—uterine cancer	0.000534	0.00215	CcSEcCtD
Almotriptan—Dry eye—Epirubicin—uterine cancer	0.000533	0.00214	CcSEcCtD
Almotriptan—Gastrointestinal pain—Medroxyprogesterone Acetate—uterine cancer	0.000532	0.00214	CcSEcCtD
Almotriptan—Myalgia—Dactinomycin—uterine cancer	0.000529	0.00213	CcSEcCtD
Almotriptan—Hypersensitivity—Progesterone—uterine cancer	0.000529	0.00213	CcSEcCtD
Almotriptan—Discomfort—Dactinomycin—uterine cancer	0.000523	0.0021	CcSEcCtD
Almotriptan—Salivary hypersecretion—Doxorubicin—uterine cancer	0.000518	0.00208	CcSEcCtD
Almotriptan—Asthenia—Progesterone—uterine cancer	0.000515	0.00207	CcSEcCtD
Almotriptan—Hypoaesthesia—Etoposide—uterine cancer	0.000514	0.00207	CcSEcCtD
Almotriptan—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	0.000514	0.00207	CcSEcCtD
Almotriptan—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	0.000514	0.00207	CcSEcCtD
Almotriptan—Colitis—Doxorubicin—uterine cancer	0.000513	0.00206	CcSEcCtD
Almotriptan—CYP2C8—vagina—uterine cancer	0.000512	0.0194	CbGeAlD
Almotriptan—Pruritus—Progesterone—uterine cancer	0.000508	0.00204	CcSEcCtD
Almotriptan—Hypertonia—Epirubicin—uterine cancer	0.000506	0.00203	CcSEcCtD
Almotriptan—Neuropathy—Doxorubicin—uterine cancer	0.000501	0.00201	CcSEcCtD
Almotriptan—Mental disability—Epirubicin—uterine cancer	0.000501	0.00201	CcSEcCtD
Almotriptan—Dry eye—Doxorubicin—uterine cancer	0.000493	0.00198	CcSEcCtD
Almotriptan—Diarrhoea—Progesterone—uterine cancer	0.000491	0.00197	CcSEcCtD
Almotriptan—Eye disorder—Etoposide—uterine cancer	0.000483	0.00194	CcSEcCtD
Almotriptan—Cardiac disorder—Etoposide—uterine cancer	0.00048	0.00193	CcSEcCtD
Almotriptan—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.000479	0.00193	CcSEcCtD
Almotriptan—CYP3A4—renal system—uterine cancer	0.000479	0.0182	CbGeAlD
Almotriptan—CYP2E1—female reproductive system—uterine cancer	0.000477	0.0181	CbGeAlD
Almotriptan—Dizziness—Progesterone—uterine cancer	0.000475	0.00191	CcSEcCtD
Almotriptan—CYP2D6—renal system—uterine cancer	0.000471	0.0179	CbGeAlD
Almotriptan—Hypertonia—Doxorubicin—uterine cancer	0.000468	0.00188	CcSEcCtD
Almotriptan—Immune system disorder—Etoposide—uterine cancer	0.000467	0.00188	CcSEcCtD
Almotriptan—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.000467	0.00188	CcSEcCtD
Almotriptan—Eye pain—Epirubicin—uterine cancer	0.000464	0.00186	CcSEcCtD
Almotriptan—Chills—Etoposide—uterine cancer	0.000464	0.00186	CcSEcCtD
Almotriptan—Mental disability—Doxorubicin—uterine cancer	0.000463	0.00186	CcSEcCtD
Almotriptan—Musculoskeletal discomfort—Dactinomycin—uterine cancer	0.000462	0.00186	CcSEcCtD
Almotriptan—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.00046	0.00185	CcSEcCtD
Almotriptan—Vomiting—Progesterone—uterine cancer	0.000456	0.00183	CcSEcCtD
Almotriptan—Rash—Progesterone—uterine cancer	0.000453	0.00182	CcSEcCtD
Almotriptan—Dermatitis—Progesterone—uterine cancer	0.000452	0.00182	CcSEcCtD
Almotriptan—Headache—Progesterone—uterine cancer	0.00045	0.00181	CcSEcCtD
Almotriptan—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.000445	0.00179	CcSEcCtD
Almotriptan—Dysgeusia—Etoposide—uterine cancer	0.000441	0.00177	CcSEcCtD
Almotriptan—Fatigue—Dactinomycin—uterine cancer	0.000437	0.00176	CcSEcCtD
Almotriptan—Back pain—Etoposide—uterine cancer	0.000435	0.00175	CcSEcCtD
Almotriptan—Pain—Dactinomycin—uterine cancer	0.000434	0.00174	CcSEcCtD
Almotriptan—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.00043	0.00173	CcSEcCtD
Almotriptan—Eye pain—Doxorubicin—uterine cancer	0.000429	0.00173	CcSEcCtD
Almotriptan—Nausea—Progesterone—uterine cancer	0.000426	0.00171	CcSEcCtD
Almotriptan—Diplopia—Epirubicin—uterine cancer	0.000419	0.00168	CcSEcCtD
Almotriptan—Pain in extremity—Epirubicin—uterine cancer	0.000419	0.00168	CcSEcCtD
Almotriptan—Feeling abnormal—Dactinomycin—uterine cancer	0.000418	0.00168	CcSEcCtD
Almotriptan—Ill-defined disorder—Etoposide—uterine cancer	0.000418	0.00168	CcSEcCtD
Almotriptan—Gastrointestinal pain—Dactinomycin—uterine cancer	0.000415	0.00167	CcSEcCtD
Almotriptan—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.000414	0.00166	CcSEcCtD
Almotriptan—Rash—Medroxyprogesterone Acetate—uterine cancer	0.00041	0.00165	CcSEcCtD
Almotriptan—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.00041	0.00165	CcSEcCtD
Almotriptan—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000408	0.00164	CcSEcCtD
Almotriptan—Malaise—Etoposide—uterine cancer	0.000406	0.00163	CcSEcCtD
Almotriptan—Vertigo—Etoposide—uterine cancer	0.000404	0.00163	CcSEcCtD
Almotriptan—Abdominal pain—Dactinomycin—uterine cancer	0.000401	0.00161	CcSEcCtD
Almotriptan—Body temperature increased—Dactinomycin—uterine cancer	0.000401	0.00161	CcSEcCtD
Almotriptan—Loss of consciousness—Etoposide—uterine cancer	0.000396	0.00159	CcSEcCtD
Almotriptan—Convulsion—Etoposide—uterine cancer	0.00039	0.00157	CcSEcCtD
Almotriptan—Hypertension—Etoposide—uterine cancer	0.000389	0.00156	CcSEcCtD
Almotriptan—Pain in extremity—Doxorubicin—uterine cancer	0.000388	0.00156	CcSEcCtD
Almotriptan—Diplopia—Doxorubicin—uterine cancer	0.000388	0.00156	CcSEcCtD
Almotriptan—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000386	0.00155	CcSEcCtD
Almotriptan—CYP3A4—female reproductive system—uterine cancer	0.000383	0.0145	CbGeAlD
Almotriptan—Chest pain—Etoposide—uterine cancer	0.000383	0.00154	CcSEcCtD
Almotriptan—Abdominal pain upper—Epirubicin—uterine cancer	0.000383	0.00154	CcSEcCtD
Almotriptan—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	0.00038	0.00153	CcSEcCtD
Almotriptan—Discomfort—Etoposide—uterine cancer	0.000379	0.00152	CcSEcCtD
Almotriptan—Breast disorder—Epirubicin—uterine cancer	0.000378	0.00152	CcSEcCtD
Almotriptan—CYP2D6—female reproductive system—uterine cancer	0.000377	0.0143	CbGeAlD
Almotriptan—Hypersensitivity—Dactinomycin—uterine cancer	0.000374	0.0015	CcSEcCtD
Almotriptan—MAOA—lymph node—uterine cancer	0.000371	0.0141	CbGeAlD
Almotriptan—Gastritis—Epirubicin—uterine cancer	0.000371	0.00149	CcSEcCtD
Almotriptan—Confusional state—Etoposide—uterine cancer	0.00037	0.00149	CcSEcCtD
Almotriptan—Muscular weakness—Epirubicin—uterine cancer	0.000369	0.00148	CcSEcCtD
Almotriptan—Anaphylactic shock—Etoposide—uterine cancer	0.000367	0.00148	CcSEcCtD
Almotriptan—Asthenia—Dactinomycin—uterine cancer	0.000364	0.00146	CcSEcCtD
Almotriptan—Tachycardia—Etoposide—uterine cancer	0.000358	0.00144	CcSEcCtD
Almotriptan—Skin disorder—Etoposide—uterine cancer	0.000357	0.00143	CcSEcCtD
Almotriptan—Hyperhidrosis—Etoposide—uterine cancer	0.000355	0.00143	CcSEcCtD
Almotriptan—Abdominal pain upper—Doxorubicin—uterine cancer	0.000354	0.00142	CcSEcCtD
Almotriptan—Angina pectoris—Epirubicin—uterine cancer	0.000353	0.00142	CcSEcCtD
Almotriptan—Breast disorder—Doxorubicin—uterine cancer	0.00035	0.00141	CcSEcCtD
Almotriptan—Bronchitis—Epirubicin—uterine cancer	0.000348	0.0014	CcSEcCtD
Almotriptan—Diarrhoea—Dactinomycin—uterine cancer	0.000347	0.0014	CcSEcCtD
Almotriptan—CYP2D6—female gonad—uterine cancer	0.000343	0.013	CbGeAlD
Almotriptan—Gastritis—Doxorubicin—uterine cancer	0.000343	0.00138	CcSEcCtD
Almotriptan—Muscular weakness—Doxorubicin—uterine cancer	0.000342	0.00137	CcSEcCtD
Almotriptan—Photosensitivity reaction—Epirubicin—uterine cancer	0.00033	0.00133	CcSEcCtD
Almotriptan—Paraesthesia—Etoposide—uterine cancer	0.00033	0.00133	CcSEcCtD
Almotriptan—Dyspnoea—Etoposide—uterine cancer	0.000327	0.00132	CcSEcCtD
Almotriptan—Hyperglycaemia—Epirubicin—uterine cancer	0.000327	0.00131	CcSEcCtD
Almotriptan—Somnolence—Etoposide—uterine cancer	0.000326	0.00131	CcSEcCtD
Almotriptan—Angina pectoris—Doxorubicin—uterine cancer	0.000326	0.00131	CcSEcCtD
Almotriptan—Vomiting—Dactinomycin—uterine cancer	0.000323	0.0013	CcSEcCtD
Almotriptan—Bronchitis—Doxorubicin—uterine cancer	0.000322	0.00129	CcSEcCtD
Almotriptan—Rash—Dactinomycin—uterine cancer	0.00032	0.00129	CcSEcCtD
Almotriptan—Gastrointestinal disorder—Etoposide—uterine cancer	0.000317	0.00127	CcSEcCtD
Almotriptan—Fatigue—Etoposide—uterine cancer	0.000317	0.00127	CcSEcCtD
Almotriptan—Neuropathy peripheral—Epirubicin—uterine cancer	0.000316	0.00127	CcSEcCtD
Almotriptan—Pain—Etoposide—uterine cancer	0.000314	0.00126	CcSEcCtD
Almotriptan—Conjunctivitis—Epirubicin—uterine cancer	0.000314	0.00126	CcSEcCtD
Almotriptan—Photosensitivity reaction—Doxorubicin—uterine cancer	0.000306	0.00123	CcSEcCtD
Almotriptan—Epistaxis—Epirubicin—uterine cancer	0.000304	0.00122	CcSEcCtD
Almotriptan—Sinusitis—Epirubicin—uterine cancer	0.000303	0.00122	CcSEcCtD
Almotriptan—Feeling abnormal—Etoposide—uterine cancer	0.000303	0.00122	CcSEcCtD
Almotriptan—Hyperglycaemia—Doxorubicin—uterine cancer	0.000302	0.00121	CcSEcCtD
Almotriptan—Nausea—Dactinomycin—uterine cancer	0.000301	0.00121	CcSEcCtD
Almotriptan—Gastrointestinal pain—Etoposide—uterine cancer	0.0003	0.00121	CcSEcCtD
Almotriptan—Neuropathy peripheral—Doxorubicin—uterine cancer	0.000293	0.00118	CcSEcCtD
Almotriptan—Rhinitis—Epirubicin—uterine cancer	0.00029	0.00117	CcSEcCtD
Almotriptan—Abdominal pain—Etoposide—uterine cancer	0.00029	0.00117	CcSEcCtD
Almotriptan—Body temperature increased—Etoposide—uterine cancer	0.00029	0.00117	CcSEcCtD
Almotriptan—Conjunctivitis—Doxorubicin—uterine cancer	0.00029	0.00117	CcSEcCtD
Almotriptan—Hypoaesthesia—Epirubicin—uterine cancer	0.000288	0.00116	CcSEcCtD
Almotriptan—Pharyngitis—Epirubicin—uterine cancer	0.000288	0.00116	CcSEcCtD
Almotriptan—Epistaxis—Doxorubicin—uterine cancer	0.000282	0.00113	CcSEcCtD
Almotriptan—Sinusitis—Doxorubicin—uterine cancer	0.00028	0.00113	CcSEcCtD
Almotriptan—Visual impairment—Epirubicin—uterine cancer	0.000279	0.00112	CcSEcCtD
Almotriptan—Eye disorder—Epirubicin—uterine cancer	0.000271	0.00109	CcSEcCtD
Almotriptan—Hypersensitivity—Etoposide—uterine cancer	0.000271	0.00109	CcSEcCtD
Almotriptan—Tinnitus—Epirubicin—uterine cancer	0.00027	0.00109	CcSEcCtD
Almotriptan—Cardiac disorder—Epirubicin—uterine cancer	0.000269	0.00108	CcSEcCtD
Almotriptan—Rhinitis—Doxorubicin—uterine cancer	0.000269	0.00108	CcSEcCtD
Almotriptan—Hypoaesthesia—Doxorubicin—uterine cancer	0.000267	0.00107	CcSEcCtD
Almotriptan—Pharyngitis—Doxorubicin—uterine cancer	0.000266	0.00107	CcSEcCtD
Almotriptan—Asthenia—Etoposide—uterine cancer	0.000263	0.00106	CcSEcCtD
Almotriptan—Immune system disorder—Epirubicin—uterine cancer	0.000262	0.00105	CcSEcCtD
Almotriptan—Chills—Epirubicin—uterine cancer	0.00026	0.00105	CcSEcCtD
Almotriptan—Pruritus—Etoposide—uterine cancer	0.00026	0.00104	CcSEcCtD
Almotriptan—Visual impairment—Doxorubicin—uterine cancer	0.000258	0.00104	CcSEcCtD
Almotriptan—Mental disorder—Epirubicin—uterine cancer	0.000254	0.00102	CcSEcCtD
Almotriptan—Erythema—Epirubicin—uterine cancer	0.000252	0.00101	CcSEcCtD
Almotriptan—Diarrhoea—Etoposide—uterine cancer	0.000251	0.00101	CcSEcCtD
Almotriptan—Eye disorder—Doxorubicin—uterine cancer	0.000251	0.00101	CcSEcCtD
Almotriptan—Tinnitus—Doxorubicin—uterine cancer	0.00025	0.001	CcSEcCtD
Almotriptan—Cardiac disorder—Doxorubicin—uterine cancer	0.000249	0.001	CcSEcCtD
Almotriptan—Tension—Epirubicin—uterine cancer	0.000248	0.000995	CcSEcCtD
Almotriptan—Dysgeusia—Epirubicin—uterine cancer	0.000247	0.000993	CcSEcCtD
Almotriptan—Nervousness—Epirubicin—uterine cancer	0.000245	0.000985	CcSEcCtD
Almotriptan—Back pain—Epirubicin—uterine cancer	0.000244	0.000981	CcSEcCtD
Almotriptan—Dizziness—Etoposide—uterine cancer	0.000243	0.000976	CcSEcCtD
Almotriptan—Immune system disorder—Doxorubicin—uterine cancer	0.000242	0.000973	CcSEcCtD
Almotriptan—Chills—Doxorubicin—uterine cancer	0.000241	0.000967	CcSEcCtD
Almotriptan—Vision blurred—Epirubicin—uterine cancer	0.000238	0.000956	CcSEcCtD
Almotriptan—Mental disorder—Doxorubicin—uterine cancer	0.000235	0.000944	CcSEcCtD
Almotriptan—Ill-defined disorder—Epirubicin—uterine cancer	0.000234	0.000941	CcSEcCtD
Almotriptan—Vomiting—Etoposide—uterine cancer	0.000234	0.000939	CcSEcCtD
Almotriptan—Erythema—Doxorubicin—uterine cancer	0.000233	0.000938	CcSEcCtD
Almotriptan—Agitation—Epirubicin—uterine cancer	0.000232	0.000932	CcSEcCtD
Almotriptan—Rash—Etoposide—uterine cancer	0.000232	0.000931	CcSEcCtD
Almotriptan—Dermatitis—Etoposide—uterine cancer	0.000231	0.00093	CcSEcCtD
Almotriptan—Headache—Etoposide—uterine cancer	0.00023	0.000925	CcSEcCtD
Almotriptan—Tension—Doxorubicin—uterine cancer	0.000229	0.000921	CcSEcCtD
Almotriptan—Dysgeusia—Doxorubicin—uterine cancer	0.000229	0.000919	CcSEcCtD
Almotriptan—Malaise—Epirubicin—uterine cancer	0.000227	0.000914	CcSEcCtD
Almotriptan—Nervousness—Doxorubicin—uterine cancer	0.000227	0.000911	CcSEcCtD
Almotriptan—Vertigo—Epirubicin—uterine cancer	0.000227	0.000911	CcSEcCtD
Almotriptan—Syncope—Epirubicin—uterine cancer	0.000226	0.000909	CcSEcCtD
Almotriptan—Back pain—Doxorubicin—uterine cancer	0.000226	0.000907	CcSEcCtD
Almotriptan—Palpitations—Epirubicin—uterine cancer	0.000223	0.000896	CcSEcCtD
Almotriptan—Loss of consciousness—Epirubicin—uterine cancer	0.000222	0.000891	CcSEcCtD
Almotriptan—Vision blurred—Doxorubicin—uterine cancer	0.00022	0.000884	CcSEcCtD
Almotriptan—Convulsion—Epirubicin—uterine cancer	0.000219	0.000878	CcSEcCtD
Almotriptan—Nausea—Etoposide—uterine cancer	0.000218	0.000877	CcSEcCtD
Almotriptan—Hypertension—Epirubicin—uterine cancer	0.000218	0.000875	CcSEcCtD
Almotriptan—Ill-defined disorder—Doxorubicin—uterine cancer	0.000217	0.00087	CcSEcCtD
Almotriptan—Chest pain—Epirubicin—uterine cancer	0.000215	0.000863	CcSEcCtD
Almotriptan—Arthralgia—Epirubicin—uterine cancer	0.000215	0.000863	CcSEcCtD
Almotriptan—Myalgia—Epirubicin—uterine cancer	0.000215	0.000863	CcSEcCtD
Almotriptan—Agitation—Doxorubicin—uterine cancer	0.000214	0.000862	CcSEcCtD
Almotriptan—Anxiety—Epirubicin—uterine cancer	0.000214	0.00086	CcSEcCtD
Almotriptan—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	0.000213	0.000857	CcSEcCtD
Almotriptan—Discomfort—Epirubicin—uterine cancer	0.000212	0.000853	CcSEcCtD
Almotriptan—Malaise—Doxorubicin—uterine cancer	0.00021	0.000846	CcSEcCtD
Almotriptan—Dry mouth—Epirubicin—uterine cancer	0.00021	0.000844	CcSEcCtD
Almotriptan—Vertigo—Doxorubicin—uterine cancer	0.00021	0.000843	CcSEcCtD
Almotriptan—Syncope—Doxorubicin—uterine cancer	0.000209	0.000841	CcSEcCtD
Almotriptan—Confusional state—Epirubicin—uterine cancer	0.000208	0.000834	CcSEcCtD
Almotriptan—Palpitations—Doxorubicin—uterine cancer	0.000206	0.000829	CcSEcCtD
Almotriptan—Anaphylactic shock—Epirubicin—uterine cancer	0.000206	0.000827	CcSEcCtD
Almotriptan—Loss of consciousness—Doxorubicin—uterine cancer	0.000205	0.000825	CcSEcCtD
Almotriptan—Shock—Epirubicin—uterine cancer	0.000203	0.000814	CcSEcCtD
Almotriptan—Convulsion—Doxorubicin—uterine cancer	0.000202	0.000813	CcSEcCtD
Almotriptan—Nervous system disorder—Epirubicin—uterine cancer	0.000202	0.000811	CcSEcCtD
Almotriptan—Hypertension—Doxorubicin—uterine cancer	0.000202	0.00081	CcSEcCtD
Almotriptan—Tachycardia—Epirubicin—uterine cancer	0.000201	0.000808	CcSEcCtD
Almotriptan—Skin disorder—Epirubicin—uterine cancer	0.0002	0.000804	CcSEcCtD
Almotriptan—Hyperhidrosis—Epirubicin—uterine cancer	0.000199	0.0008	CcSEcCtD
Almotriptan—Arthralgia—Doxorubicin—uterine cancer	0.000199	0.000799	CcSEcCtD
Almotriptan—Chest pain—Doxorubicin—uterine cancer	0.000199	0.000799	CcSEcCtD
Almotriptan—Myalgia—Doxorubicin—uterine cancer	0.000199	0.000799	CcSEcCtD
Almotriptan—Anxiety—Doxorubicin—uterine cancer	0.000198	0.000796	CcSEcCtD
Almotriptan—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	0.000197	0.000793	CcSEcCtD
Almotriptan—Discomfort—Doxorubicin—uterine cancer	0.000196	0.000789	CcSEcCtD
Almotriptan—Dry mouth—Doxorubicin—uterine cancer	0.000194	0.000781	CcSEcCtD
Almotriptan—Confusional state—Doxorubicin—uterine cancer	0.000192	0.000772	CcSEcCtD
Almotriptan—Anaphylactic shock—Doxorubicin—uterine cancer	0.00019	0.000766	CcSEcCtD
Almotriptan—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.000188	0.000754	CcSEcCtD
Almotriptan—Shock—Doxorubicin—uterine cancer	0.000187	0.000753	CcSEcCtD
Almotriptan—Nervous system disorder—Doxorubicin—uterine cancer	0.000187	0.000751	CcSEcCtD
Almotriptan—Insomnia—Epirubicin—uterine cancer	0.000186	0.000748	CcSEcCtD
Almotriptan—Tachycardia—Doxorubicin—uterine cancer	0.000186	0.000747	CcSEcCtD
Almotriptan—Skin disorder—Doxorubicin—uterine cancer	0.000185	0.000744	CcSEcCtD
Almotriptan—Paraesthesia—Epirubicin—uterine cancer	0.000185	0.000743	CcSEcCtD
Almotriptan—Hyperhidrosis—Doxorubicin—uterine cancer	0.000184	0.00074	CcSEcCtD
Almotriptan—Dyspnoea—Epirubicin—uterine cancer	0.000184	0.000738	CcSEcCtD
Almotriptan—Somnolence—Epirubicin—uterine cancer	0.000183	0.000736	CcSEcCtD
Almotriptan—Dyspepsia—Epirubicin—uterine cancer	0.000181	0.000728	CcSEcCtD
Almotriptan—Gastrointestinal disorder—Epirubicin—uterine cancer	0.000178	0.000714	CcSEcCtD
Almotriptan—Fatigue—Epirubicin—uterine cancer	0.000177	0.000713	CcSEcCtD
Almotriptan—Pain—Epirubicin—uterine cancer	0.000176	0.000708	CcSEcCtD
Almotriptan—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.000174	0.000698	CcSEcCtD
Almotriptan—Insomnia—Doxorubicin—uterine cancer	0.000172	0.000693	CcSEcCtD
Almotriptan—Paraesthesia—Doxorubicin—uterine cancer	0.000171	0.000688	CcSEcCtD
Almotriptan—Dyspnoea—Doxorubicin—uterine cancer	0.00017	0.000683	CcSEcCtD
Almotriptan—Feeling abnormal—Epirubicin—uterine cancer	0.00017	0.000682	CcSEcCtD
Almotriptan—Somnolence—Doxorubicin—uterine cancer	0.000169	0.000681	CcSEcCtD
Almotriptan—Gastrointestinal pain—Epirubicin—uterine cancer	0.000168	0.000677	CcSEcCtD
Almotriptan—Dyspepsia—Doxorubicin—uterine cancer	0.000168	0.000674	CcSEcCtD
Almotriptan—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.000164	0.000661	CcSEcCtD
Almotriptan—Fatigue—Doxorubicin—uterine cancer	0.000164	0.00066	CcSEcCtD
Almotriptan—Pain—Doxorubicin—uterine cancer	0.000163	0.000655	CcSEcCtD
Almotriptan—Body temperature increased—Epirubicin—uterine cancer	0.000163	0.000654	CcSEcCtD
Almotriptan—Abdominal pain—Epirubicin—uterine cancer	0.000163	0.000654	CcSEcCtD
Almotriptan—Feeling abnormal—Doxorubicin—uterine cancer	0.000157	0.000631	CcSEcCtD
Almotriptan—Gastrointestinal pain—Doxorubicin—uterine cancer	0.000156	0.000626	CcSEcCtD
Almotriptan—Hypersensitivity—Epirubicin—uterine cancer	0.000152	0.00061	CcSEcCtD
Almotriptan—Body temperature increased—Doxorubicin—uterine cancer	0.000151	0.000605	CcSEcCtD
Almotriptan—Abdominal pain—Doxorubicin—uterine cancer	0.000151	0.000605	CcSEcCtD
Almotriptan—Asthenia—Epirubicin—uterine cancer	0.000148	0.000594	CcSEcCtD
Almotriptan—Pruritus—Epirubicin—uterine cancer	0.000146	0.000585	CcSEcCtD
Almotriptan—Diarrhoea—Epirubicin—uterine cancer	0.000141	0.000566	CcSEcCtD
Almotriptan—Hypersensitivity—Doxorubicin—uterine cancer	0.00014	0.000564	CcSEcCtD
Almotriptan—Asthenia—Doxorubicin—uterine cancer	0.000137	0.000549	CcSEcCtD
Almotriptan—Dizziness—Epirubicin—uterine cancer	0.000136	0.000547	CcSEcCtD
Almotriptan—Pruritus—Doxorubicin—uterine cancer	0.000135	0.000542	CcSEcCtD
Almotriptan—Vomiting—Epirubicin—uterine cancer	0.000131	0.000526	CcSEcCtD
Almotriptan—Diarrhoea—Doxorubicin—uterine cancer	0.00013	0.000524	CcSEcCtD
Almotriptan—Rash—Epirubicin—uterine cancer	0.00013	0.000522	CcSEcCtD
Almotriptan—Dermatitis—Epirubicin—uterine cancer	0.00013	0.000521	CcSEcCtD
Almotriptan—Headache—Epirubicin—uterine cancer	0.000129	0.000518	CcSEcCtD
Almotriptan—Dizziness—Doxorubicin—uterine cancer	0.000126	0.000506	CcSEcCtD
Almotriptan—Nausea—Epirubicin—uterine cancer	0.000122	0.000492	CcSEcCtD
Almotriptan—Vomiting—Doxorubicin—uterine cancer	0.000121	0.000487	CcSEcCtD
Almotriptan—Rash—Doxorubicin—uterine cancer	0.00012	0.000483	CcSEcCtD
Almotriptan—Dermatitis—Doxorubicin—uterine cancer	0.00012	0.000482	CcSEcCtD
Almotriptan—Headache—Doxorubicin—uterine cancer	0.000119	0.00048	CcSEcCtD
Almotriptan—Nausea—Doxorubicin—uterine cancer	0.000113	0.000455	CcSEcCtD
Almotriptan—CYP2C19—Metabolism of lipids and lipoproteins—STAR—uterine cancer	3.46e-05	0.00182	CbGpPWpGaD
Almotriptan—HTR1D—G alpha (i) signalling events—CXCL8—uterine cancer	3.46e-05	0.00182	CbGpPWpGaD
Almotriptan—CYP3A4—Metapathway biotransformation—GPX3—uterine cancer	3.44e-05	0.00182	CbGpPWpGaD
Almotriptan—MAOA—SIDS Susceptibility Pathways—VEGFA—uterine cancer	3.42e-05	0.0018	CbGpPWpGaD
Almotriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—CCL2—uterine cancer	3.4e-05	0.0018	CbGpPWpGaD
Almotriptan—HTR1B—G alpha (i) signalling events—CXCL8—uterine cancer	3.38e-05	0.00179	CbGpPWpGaD
Almotriptan—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—uterine cancer	3.35e-05	0.00177	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—AKR1B10—uterine cancer	3.33e-05	0.00176	CbGpPWpGaD
Almotriptan—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—uterine cancer	3.31e-05	0.00175	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—AKR1B10—uterine cancer	3.26e-05	0.00172	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—STAR—uterine cancer	3.25e-05	0.00172	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—AKR1B1—uterine cancer	3.25e-05	0.00172	CbGpPWpGaD
Almotriptan—CYP3A4—Biological oxidations—CYP11A1—uterine cancer	3.24e-05	0.00171	CbGpPWpGaD
Almotriptan—CYP3A4—Metapathway biotransformation—CYP11A1—uterine cancer	3.19e-05	0.00169	CbGpPWpGaD
Almotriptan—CYP1A2—Biological oxidations—CYP19A1—uterine cancer	3.09e-05	0.00163	CbGpPWpGaD
Almotriptan—CYP1A2—Metapathway biotransformation—CYP19A1—uterine cancer	3.05e-05	0.00161	CbGpPWpGaD
Almotriptan—CYP3A4—Metapathway biotransformation—AKR1C3—uterine cancer	3.02e-05	0.00159	CbGpPWpGaD
Almotriptan—FMO3—Metabolism—STK11—uterine cancer	3e-05	0.00158	CbGpPWpGaD
Almotriptan—FMO3—Metabolism—CYP19A1—uterine cancer	3e-05	0.00158	CbGpPWpGaD
Almotriptan—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—uterine cancer	2.85e-05	0.0015	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	2.84e-05	0.0015	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—RNF43—uterine cancer	2.76e-05	0.00146	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—NDUFB11—uterine cancer	2.76e-05	0.00146	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—SRD5A2—uterine cancer	2.76e-05	0.00146	CbGpPWpGaD
Almotriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—CXCL8—uterine cancer	2.75e-05	0.00145	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—RNF43—uterine cancer	2.71e-05	0.00143	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	2.69e-05	0.00142	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism of lipids and lipoproteins—STAR—uterine cancer	2.69e-05	0.00142	CbGpPWpGaD
Almotriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—CXCL8—uterine cancer	2.69e-05	0.00142	CbGpPWpGaD
Almotriptan—HTR1D—GPCR ligand binding—CCL2—uterine cancer	2.65e-05	0.0014	CbGpPWpGaD
Almotriptan—HTR1B—GPCR ligand binding—CCL2—uterine cancer	2.59e-05	0.00137	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—POLD1—uterine cancer	2.55e-05	0.00135	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	2.54e-05	0.00134	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—INHBA—uterine cancer	2.53e-05	0.00133	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—INHBA—uterine cancer	2.47e-05	0.00131	CbGpPWpGaD
Almotriptan—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—uterine cancer	2.42e-05	0.00128	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—AKR1C1—uterine cancer	2.39e-05	0.00126	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—NDUFB11—uterine cancer	2.39e-05	0.00126	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—SRD5A2—uterine cancer	2.39e-05	0.00126	CbGpPWpGaD
Almotriptan—CYP3A4—Biological oxidations—CYP19A1—uterine cancer	2.38e-05	0.00126	CbGpPWpGaD
Almotriptan—CYP3A4—Metapathway biotransformation—CYP19A1—uterine cancer	2.35e-05	0.00124	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	2.32e-05	0.00122	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—AKR1C1—uterine cancer	2.28e-05	0.0012	CbGpPWpGaD
Almotriptan—FMO3—Metabolism—MTHFR—uterine cancer	2.25e-05	0.00119	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—AKR1C1—uterine cancer	2.23e-05	0.00118	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	2.19e-05	0.00115	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—SRD5A2—uterine cancer	2.13e-05	0.00112	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—NDUFB11—uterine cancer	2.13e-05	0.00112	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—RRM2—uterine cancer	2.13e-05	0.00112	CbGpPWpGaD
Almotriptan—HTR1D—GPCR ligand binding—CXCL8—uterine cancer	2.09e-05	0.0011	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	2.07e-05	0.00109	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—DCN—uterine cancer	2.07e-05	0.00109	CbGpPWpGaD
Almotriptan—HTR1B—GPCR ligand binding—CXCL8—uterine cancer	2.05e-05	0.00108	CbGpPWpGaD
Almotriptan—MAOA—Transmission across Chemical Synapses—HRAS—uterine cancer	2.02e-05	0.00107	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—AKR1B1—uterine cancer	2e-05	0.00105	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—STAR—uterine cancer	2e-05	0.00105	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	1.98e-05	0.00104	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—SRD5A2—uterine cancer	1.96e-05	0.00103	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—NDUFB11—uterine cancer	1.96e-05	0.00103	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	1.95e-05	0.00103	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—CYP11A1—uterine cancer	1.95e-05	0.00103	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—AKR1C3—uterine cancer	1.84e-05	0.00097	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—AKR1C3—uterine cancer	1.75e-05	0.000924	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—AKR1B1—uterine cancer	1.72e-05	0.00091	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—STAR—uterine cancer	1.72e-05	0.00091	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—AKR1C3—uterine cancer	1.71e-05	0.000905	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—PGR—uterine cancer	1.71e-05	0.000901	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	1.71e-05	0.0009	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—PGR—uterine cancer	1.67e-05	0.000882	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—NDUFB11—uterine cancer	1.66e-05	0.000876	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—SRD5A2—uterine cancer	1.66e-05	0.000876	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—YWHAE—uterine cancer	1.63e-05	0.000859	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	1.61e-05	0.000851	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—YWHAE—uterine cancer	1.59e-05	0.000841	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—POLD1—uterine cancer	1.57e-05	0.000826	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—FBXW7—uterine cancer	1.56e-05	0.000824	CbGpPWpGaD
Almotriptan—MAOA—Neuronal System—HRAS—uterine cancer	1.55e-05	0.000819	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—AKR1B1—uterine cancer	1.54e-05	0.000813	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—STAR—uterine cancer	1.54e-05	0.000813	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—FBXW7—uterine cancer	1.53e-05	0.000807	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	1.52e-05	0.000803	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	1.52e-05	0.000803	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—AKR1C1—uterine cancer	1.46e-05	0.000773	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—STK11—uterine cancer	1.43e-05	0.000756	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—CYP19A1—uterine cancer	1.43e-05	0.000756	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—STAR—uterine cancer	1.42e-05	0.000747	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—AKR1B1—uterine cancer	1.42e-05	0.000747	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—STK11—uterine cancer	1.36e-05	0.00072	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—CCL2—uterine cancer	1.36e-05	0.000717	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—POLD1—uterine cancer	1.35e-05	0.000714	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—STK11—uterine cancer	1.34e-05	0.000705	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—CCL2—uterine cancer	1.33e-05	0.000702	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—RRM2—uterine cancer	1.31e-05	0.000689	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—NDUFB11—uterine cancer	1.28e-05	0.000676	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—SRD5A2—uterine cancer	1.28e-05	0.000676	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—SOCS3—uterine cancer	1.28e-05	0.000674	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—DCN—uterine cancer	1.27e-05	0.000669	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—AKR1C1—uterine cancer	1.27e-05	0.000668	CbGpPWpGaD
Almotriptan—FMO3—Metabolism—PTEN—uterine cancer	1.25e-05	0.000661	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—SOCS3—uterine cancer	1.25e-05	0.00066	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—CDKN2B—uterine cancer	1.22e-05	0.000646	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—POLD1—uterine cancer	1.21e-05	0.000638	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—AKR1B1—uterine cancer	1.2e-05	0.000633	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—STAR—uterine cancer	1.2e-05	0.000633	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—CDKN2B—uterine cancer	1.2e-05	0.000632	CbGpPWpGaD
Almotriptan—FMO3—Metabolism—EP300—uterine cancer	1.19e-05	0.00063	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—CYP11A1—uterine cancer	1.19e-05	0.00063	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—IGF1R—uterine cancer	1.19e-05	0.000627	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	1.19e-05	0.000626	CbGpPWpGaD
Almotriptan—HTR1D—GPCR downstream signaling—CXCL8—uterine cancer	1.18e-05	0.000624	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—IGF1R—uterine cancer	1.16e-05	0.000614	CbGpPWpGaD
Almotriptan—HTR1B—GPCR downstream signaling—CXCL8—uterine cancer	1.16e-05	0.000611	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—AKR1C1—uterine cancer	1.13e-05	0.000596	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—RRM2—uterine cancer	1.13e-05	0.000596	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—AKR1C3—uterine cancer	1.13e-05	0.000595	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—SMAD3—uterine cancer	1.12e-05	0.000589	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—POLD1—uterine cancer	1.11e-05	0.000586	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—DCN—uterine cancer	1.1e-05	0.000578	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—SMAD3—uterine cancer	1.09e-05	0.000577	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—MTHFR—uterine cancer	1.08e-05	0.000568	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—CXCL8—uterine cancer	1.07e-05	0.000567	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—FGFR2—uterine cancer	1.07e-05	0.000562	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—CXCL8—uterine cancer	1.05e-05	0.000555	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—FGFR2—uterine cancer	1.04e-05	0.00055	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—AKR1C1—uterine cancer	1.04e-05	0.000549	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—CYP11A1—uterine cancer	1.03e-05	0.000545	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—RRM2—uterine cancer	1.01e-05	0.000532	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—DCN—uterine cancer	9.78e-06	0.000516	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—AKR1C3—uterine cancer	9.75e-06	0.000514	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—POLD1—uterine cancer	9.41e-06	0.000497	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—RRM2—uterine cancer	9.26e-06	0.000489	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—AKR1B1—uterine cancer	9.26e-06	0.000489	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—STAR—uterine cancer	9.26e-06	0.000489	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—CYP11A1—uterine cancer	9.21e-06	0.000486	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—ESR1—uterine cancer	9.11e-06	0.000481	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—DCN—uterine cancer	8.99e-06	0.000475	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—ESR1—uterine cancer	8.92e-06	0.000471	CbGpPWpGaD
Almotriptan—FMO3—Metabolism—PIK3CA—uterine cancer	8.84e-06	0.000466	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—AKR1C1—uterine cancer	8.81e-06	0.000465	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—CYP19A1—uterine cancer	8.79e-06	0.000464	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—STK11—uterine cancer	8.79e-06	0.000464	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—AKR1C3—uterine cancer	8.7e-06	0.000459	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—NRAS—uterine cancer	8.62e-06	0.000455	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—CYP11A1—uterine cancer	8.47e-06	0.000447	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—NRAS—uterine cancer	8.44e-06	0.000445	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—CCL2—uterine cancer	8.02e-06	0.000423	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—AKR1C3—uterine cancer	8e-06	0.000422	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—CCL2—uterine cancer	7.86e-06	0.000415	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—RRM2—uterine cancer	7.85e-06	0.000414	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—DCN—uterine cancer	7.62e-06	0.000402	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—STK11—uterine cancer	7.59e-06	0.000401	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—CYP19A1—uterine cancer	7.59e-06	0.000401	CbGpPWpGaD
Almotriptan—HTR1D—GPCR downstream signaling—PIK3CA—uterine cancer	7.5e-06	0.000396	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—KRAS—uterine cancer	7.41e-06	0.000391	CbGpPWpGaD
Almotriptan—HTR1B—GPCR downstream signaling—PIK3CA—uterine cancer	7.35e-06	0.000388	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—POLD1—uterine cancer	7.27e-06	0.000383	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—KRAS—uterine cancer	7.26e-06	0.000383	CbGpPWpGaD
Almotriptan—FMO3—Metabolism—AKT1—uterine cancer	7.22e-06	0.000381	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—CYP11A1—uterine cancer	7.18e-06	0.000379	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	7.13e-06	0.000376	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—PIK3CA—uterine cancer	6.81e-06	0.000359	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism of lipids and lipoproteins—EP300—uterine cancer	6.8e-06	0.000359	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—AKR1C1—uterine cancer	6.8e-06	0.000359	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—AKR1C3—uterine cancer	6.78e-06	0.000358	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—CYP19A1—uterine cancer	6.78e-06	0.000358	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—STK11—uterine cancer	6.78e-06	0.000358	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—ERBB2—uterine cancer	6.69e-06	0.000353	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—PIK3CA—uterine cancer	6.67e-06	0.000352	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—MTHFR—uterine cancer	6.6e-06	0.000348	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—ERBB2—uterine cancer	6.55e-06	0.000346	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	6.36e-06	0.000336	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—CXCL8—uterine cancer	6.34e-06	0.000335	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—HRAS—uterine cancer	6.3e-06	0.000333	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—CYP19A1—uterine cancer	6.23e-06	0.000329	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—STK11—uterine cancer	6.23e-06	0.000329	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—CXCL8—uterine cancer	6.21e-06	0.000328	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—CDKN1B—uterine cancer	6.2e-06	0.000327	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—HRAS—uterine cancer	6.17e-06	0.000326	CbGpPWpGaD
Almotriptan—HTR1D—GPCR downstream signaling—AKT1—uterine cancer	6.13e-06	0.000323	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism of lipids and lipoproteins—EP300—uterine cancer	6.07e-06	0.00032	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—CDKN1B—uterine cancer	6.07e-06	0.00032	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—RRM2—uterine cancer	6.06e-06	0.00032	CbGpPWpGaD
Almotriptan—HTR1B—GPCR downstream signaling—AKT1—uterine cancer	6e-06	0.000317	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—PTEN—uterine cancer	5.99e-06	0.000316	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—DCN—uterine cancer	5.88e-06	0.00031	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—CTNNB1—uterine cancer	5.85e-06	0.000309	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—CTNNB1—uterine cancer	5.73e-06	0.000302	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—EP300—uterine cancer	5.71e-06	0.000301	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—MTHFR—uterine cancer	5.71e-06	0.000301	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—PTEN—uterine cancer	5.7e-06	0.000301	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—PTEN—uterine cancer	5.59e-06	0.000295	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—AKT1—uterine cancer	5.56e-06	0.000294	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—CYP11A1—uterine cancer	5.54e-06	0.000292	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—AKT1—uterine cancer	5.45e-06	0.000288	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—EP300—uterine cancer	5.44e-06	0.000287	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—EP300—uterine cancer	5.33e-06	0.000281	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—STK11—uterine cancer	5.28e-06	0.000279	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—CYP19A1—uterine cancer	5.28e-06	0.000279	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—AKR1C3—uterine cancer	5.23e-06	0.000276	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—VEGFA—uterine cancer	5.15e-06	0.000272	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—MTHFR—uterine cancer	5.09e-06	0.000269	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—NRAS—uterine cancer	5.09e-06	0.000269	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—VEGFA—uterine cancer	5.04e-06	0.000266	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	5.03e-06	0.000265	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—NRAS—uterine cancer	4.98e-06	0.000263	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	4.96e-06	0.000262	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism of lipids and lipoproteins—EP300—uterine cancer	4.73e-06	0.000249	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—MTHFR—uterine cancer	4.68e-06	0.000247	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	4.49e-06	0.000237	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—KRAS—uterine cancer	4.38e-06	0.000231	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—KRAS—uterine cancer	4.29e-06	0.000226	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—PIK3CA—uterine cancer	4.22e-06	0.000223	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—CYP19A1—uterine cancer	4.08e-06	0.000215	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—STK11—uterine cancer	4.08e-06	0.000215	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—PIK3CA—uterine cancer	4.02e-06	0.000212	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—MTHFR—uterine cancer	3.97e-06	0.000209	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—PIK3CA—uterine cancer	3.94e-06	0.000208	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—TP53—uterine cancer	3.89e-06	0.000205	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—TP53—uterine cancer	3.81e-06	0.000201	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—HRAS—uterine cancer	3.72e-06	0.000196	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—PTEN—uterine cancer	3.67e-06	0.000194	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—HRAS—uterine cancer	3.65e-06	0.000192	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—EP300—uterine cancer	3.5e-06	0.000185	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	3.5e-06	0.000185	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—AKT1—uterine cancer	3.45e-06	0.000182	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—AKT1—uterine cancer	3.29e-06	0.000173	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—AKT1—uterine cancer	3.22e-06	0.00017	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—PTEN—uterine cancer	3.17e-06	0.000168	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—MTHFR—uterine cancer	3.06e-06	0.000162	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—EP300—uterine cancer	3.03e-06	0.00016	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—PTEN—uterine cancer	2.83e-06	0.00015	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—EP300—uterine cancer	2.7e-06	0.000143	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—PTEN—uterine cancer	2.61e-06	0.000138	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—PIK3CA—uterine cancer	2.59e-06	0.000137	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—EP300—uterine cancer	2.49e-06	0.000131	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—PIK3CA—uterine cancer	2.24e-06	0.000118	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—PTEN—uterine cancer	2.21e-06	0.000117	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—AKT1—uterine cancer	2.12e-06	0.000112	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—EP300—uterine cancer	2.11e-06	0.000111	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—PIK3CA—uterine cancer	2e-06	0.000105	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—PIK3CA—uterine cancer	1.84e-06	9.7e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—AKT1—uterine cancer	1.83e-06	9.65e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—PTEN—uterine cancer	1.7e-06	8.99e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—AKT1—uterine cancer	1.63e-06	8.62e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—EP300—uterine cancer	1.62e-06	8.57e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—PIK3CA—uterine cancer	1.56e-06	8.22e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—AKT1—uterine cancer	1.5e-06	7.93e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—AKT1—uterine cancer	1.27e-06	6.71e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—PIK3CA—uterine cancer	1.2e-06	6.34e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—AKT1—uterine cancer	9.82e-07	5.18e-05	CbGpPWpGaD
